SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-012910
Filing Date
2024-04-03
Accepted
2024-04-03 08:00:23
Documents
27
Period of Report
2024-04-03
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39610
2 ex99-1.htm EX-99.1 49647
3 ex99-2.htm EX-99.2 13898
4 ex99-1_001.jpg GRAPHIC 4559
5 ex99-2_001.jpg GRAPHIC 345535
6 ex99-2_002.jpg GRAPHIC 572327
7 ex99-2_003.jpg GRAPHIC 329580
8 ex99-2_004.jpg GRAPHIC 1495382
9 ex99-2_005.jpg GRAPHIC 364671
10 ex99-2_006.jpg GRAPHIC 337841
11 ex99-2_007.jpg GRAPHIC 294203
12 ex99-2_008.jpg GRAPHIC 420279
13 ex99-2_009.jpg GRAPHIC 381122
14 ex99-2_010.jpg GRAPHIC 325921
15 ex99-2_011.jpg GRAPHIC 376814
  Complete submission text file 0001493152-24-012910.txt   7512360

Data Files

Seq Description Document Type Size
16 XBRL SCHEMA FILE vbiv-20240403.xsd EX-101.SCH 3024
17 XBRL LABEL FILE vbiv-20240403_lab.xml EX-101.LAB 34240
18 XBRL PRESENTATION FILE vbiv-20240403_pre.xml EX-101.PRE 22365
31 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3488
Mailing Address 160 SECOND STREET CAMBRIDGE CAMBRIDGE MA 02142
Business Address 160 SECOND STREET CAMBRIDGE CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37769 | Film No.: 24816884
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)